Biochemistry
-
Hodges lab sheds new light on mechanisms of gene regulatory divergence between species
The labs of Emily Hodges, assistant professor of biochemistry, and Tony Capra, associate professor of epidemiology and biostatistics at the University of California, San Francisco, have devised a method to separate the relative contributions of cis vs. trans regulatory mechanisms to gene regulatory divergence between species. Read MoreApr. 18, 2024
-
Pietenpol to receive American Society of Clinical Oncology’s highest honor
Jennifer Pietenpol, Executive Vice President for Research and chief scientific and strategy officer for VUMC and professor of biochemistry and otolaryngology, is the 2024 recipient of the Science of Oncology Award, for outstanding contributions to basic or translational research in cancer. She is among a select group of global oncology leaders being recognized with special awards by ASCO and Conquer Cancer, the organization’s foundation. Read MoreApr. 11, 2024
-
Fourteen biomedical sciences students receive 2024 Provost Pathbreaking Discovery Award
Fourteen biomedical sciences students from across the School of Medicine Basic Sciences and the School of Medicine have been awarded the Provost Pathbreaking Discovery Award from the Graduate School. Read MoreApr. 10, 2024
-
Celebrating recent appointments and promotions in the School of Medicine Basic Sciences
Congratulations to our School of Medicine Basic Sciences community members who were promoted or received new appointments from January to March 2024! These individuals significantly enrich our pursuit of pathbreaking research and contribute to the growth and success of our school. Read MoreApr. 4, 2024
-
Vanderbilt biochemists contribute to breakthrough discovery of first new antibacterial class in decades
Led by Neil Osheroff, Vanderbilt researchers are the first to undertake a systematic analysis of the mechanism of action of geoptidacin. Gepotidacin is poised to become the first new class of antibacterials to be approved for use in humans in decades. Read MoreMar. 26, 2024
-
Taking a Bite Out of Charcot-Marie-Tooth Disease
“You’re nervous because you don't know what to expect and excited to see whatever it is you get to see,” Schlafly said of the visit. "I had seen a lab before, but I must say, it’s a pretty humbling experience to go from thinking there is no one at all who knows about your really weird, rare disease to walking into a lab and learning that everyone there is in some way working to cure my issue.” Read MoreMar. 18, 2024
-
Vanderbilt basic scientists receive National Science Foundation grant to explore RNA behavior
Manuel Ascano and Alissa Weaver are one of nine research teams to receive funding to understand the potential biotechnological uses of RNA more fully. The research is expected to provide opportunities to partner with industry to translate knowledge gained in the laboratory into marketable new therapeutics. Read MoreMar. 18, 2024
-
Q&A: Illuminating a critical step in initiating DNA replication in eukaryotes
Brandt Eichman and Walter Chazin, professors of biochemistry, worked together to provide a better understanding of how exactly DNA replication is initiated. Their work will influence novel small molecule modifier designs that may serve as tools for detailed studies of DNA replication in cells and eventual therapies. Read MoreMar. 15, 2024
-
Spotlight: Barrier breakers
By putting one foot in front of another, these trailblazers have changed Vanderbilt—and the world—with their dedication to basic research and breaking down barriers for themselves and others. Read MoreMar. 7, 2024
-
Five Basic Sciences faculty named to Vanderbilt University 2024 endowed chair cohort
Bruce Carter, Lisa Monteggia, Richard O’Brien, Andrea Page-McCaw, and Kevin Schey have been named endowed chairs, the highest academic award that Vanderbilt can give to a faculty member. Read MoreMar. 1, 2024